Publications

Selected publications

Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness. (Journal article - 2024)
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa. (Journal article - 2024)
Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced Acinetobacter baumannii persisters. (Journal article - 2023)
Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections. (Journal article - 2022)
The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology. (Journal article - 2018)

Filter publications

What type of publication do you want to show?

All

Journals

Conference papers

Chapters

Books

Other

2025

Combining antibiotics to tackle antimicrobial resistance.

Hope, W., Nambiar, S., O'Brien, S., Sharland, M., Paterson, D. L., Yin, M., . . . Pre-X Investigators. (2025). Combining antibiotics to tackle antimicrobial resistance.. Nat Microbiol. doi:10.1038/s41564-025-01969-x

DOI: 10.1038/s41564-025-01969-x
: Journal article

Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation.

Darlow, C. A., Hope, W., & Dubey, V. (2025). Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation.. Expert opinion on drug metabolism & toxicology, 21(2), 115-123. doi:10.1080/17425255.2024.2427310

DOI: 10.1080/17425255.2024.2427310
: Journal article

2024

Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef.

Owen, V., Harper, N., Dubey, V., Gerada, A., Boyd, S. E., & Darlow, C. A. (2024). Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 30(12), 1606-1608. doi:10.1016/j.cmi.2024.07.017

DOI: 10.1016/j.cmi.2024.07.017
: Journal article

Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness.

Dubey, V., Farrington, N., Harper, N., Johnson, A., Horner, I., Stevenson, A., . . . Hope, W. (2024). Acinetobacter baumannii transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness.. Antimicrobial agents and chemotherapy, 68(10), e0022224. doi:10.1128/aac.00222-24

DOI: 10.1128/aac.00222-24
: Journal article

Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication.

Sett, A., Dubey, V., Bhowmik, S., & Pathania, R. (2024). Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication.. ACS infectious diseases, 10(8), 2525-2539. doi:10.1021/acsinfecdis.4c00270

DOI: 10.1021/acsinfecdis.4c00270
: Journal article

Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa.

Farrington, N., Dubey, V., Johnson, A., Horner, I., Stevenson, A., Unsworth, J., . . . Darlow, C. A. (2024). Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa.. mBio, 15(2), e0316523. doi:10.1128/mbio.03165-23

DOI: 10.1128/mbio.03165-23
: Journal article

2023

Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced Acinetobacter baumannii persisters.

Dubey, V., Gupta, R., & Pathania, R. (2023). Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced Acinetobacter baumannii persisters.. Antimicrobial agents and chemotherapy, 95(5), AAC.02180-AAC.02120. doi:10.1128/aac.02180-20

DOI: 10.1128/aac.02180-20
: Journal article

2022

Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.

Dubey, V., Devnath, K., Gupta, V. K., Kalyan, G., Singh, M., Kothari, A., . . . Pathania, R. (2022). Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.. The Journal of antimicrobial chemotherapy, 77(5), 1313-1323. doi:10.1093/jac/dkac057

DOI: 10.1093/jac/dkac057
: Journal article

2019

Biofilms in Antimicrobial Activity and Drug Resistance

Bhando, T., Dubey, V., & Pathania, R. (2019). Biofilms in Antimicrobial Activity and Drug Resistance. Unknown Journal, 109-139. doi:10.1007/978-981-13-8503-2_6

DOI: 10.1007/978-981-13-8503-2_6
: Journal article

Computational Prediction of sRNA in Acinetobacter baumannii.

Arya, S., Dubey, V., Sen, D., Sharma, A., & Pathania, R. (2019). Computational Prediction of sRNA in Acinetobacter baumannii.. Methods in molecular biology (Clifton, N.J.), 1946, 307-320. doi:10.1007/978-1-4939-9118-1_27

DOI: 10.1007/978-1-4939-9118-1_27
: Journal article

2018

The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology.

Sharma, A., Dubey, V., Sharma, R., Devnath, K., Gupta, V. K., Akhter, J., . . . Pathania, R. (2018). The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology.. The Journal of biological chemistry, 293(35), 13377-13388. doi:10.1074/jbc.ra118.002921

DOI: 10.1074/jbc.ra118.002921
: Journal article

Dr Vineet Dubey
BTech, PhD